Therefore, melatonin alleviates glycolipid metabolism disorders by activating the AMPKα/PPARα signaling pathway, reducing lipid deposition in the liver and adipose tissues, and increasing insulin sensitivity. This evidence concerns the gene INS and metabolic process.